Tag - BNGO

Developments

MolDX issues Bionano proposed LCD

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (NASDAQ: BNGO) has announced that MolDX, a program that assesses molecular diagnostic technologies on behalf of Medicare Administrative Contractors...

September 10, 2026

Markets

BTIG assumes coverage of Bionano Genomics at buy; PT $3.50

BTIG analyst Mark Massaro assumed coverage of Bionano Genomics (NASDAQ:BNGO) with a “buy” rating and price target of $3.50. The stock closed at $2.16 on Dec. 9. Bionano provides optical genome mapping technology tools...

December 12, 2022

Developments

Bionano Genomics acquires Lineagen to boost genetics diagnostics

Bionano Genomics (NASDAQ:BNGO) acquired closely-held Lineagen, a genetics diagnostic company, to further support its leadership in digital cytogenetics and comprehensive genetic diagnostics for pediatric...

August 24, 2020

Tag - BNGO

MolDX issues Bionano proposed LCD

BTIG assumes coverage of Bionano Genomics at buy; PT $3.50

Bionano Genomics acquires Lineagen to boost genetics diagnostics

Subscribe